LMRI Stock Summary and Trading Ideas (Lumexa Imaging Hldgs | NASDAQ:LMRI)

Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.

Lumexa Imaging Hldgs trades on the NASDAQ stock market under the symbol LMRI.

As of November 12, 2026, LMRI stock price declined to $14.94 with 365,940 million shares trading.

LMRI has a beta of 0.65, meaning it tends to be less sensitive to market movements. LMRI has a correlation of 0.01 to the broad based SPY ETF.

LMRI has a market cap of $1.44 billion. This is considered a Small Cap stock.

Last quarter Lumexa Imaging Hldgs reported $272 million in Revenue and $.26 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.10.

The top ETF exchange traded funds that LMRI belongs to (by Net Assets): VTI, IWM, VXF, IWN, SCHA.

LMRI support price is $15.33 and resistance is $16.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LMRI shares will trade within this expected range on the day.